US · BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Billerica, MA 01821
- Website
- bruker.com
Price at previous close
$451.04
Market cap 48.79B
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $5.50 | $14.15 | |||
| 2011 | $5.96 | $18.74 | |||
| 2012 | $5.89 | $7.55 | |||
| 2013 | $6.75 | $5.11 | |||
| 2014 | $5.53 | $2.23 | |||
| 2015 | $6.60 | $0.00 | |||
| 2016 | $5.85 | $7.01 | |||
| 2017 | $3.64 | $8.61 | |||
| 2018 | $7.37 | $17.50 | |||
| 2019 | $7.96 | $21.75 | |||
| 2020 | $7.01 | $4.23 | |||
| 2021 | $11.68 | $52.70 | |||
| 2022 | $11.47 | $25.01 | |||
| 2023 | $17.00 | $71.73 | |||
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| BRKRP | Bruker Corporation 6.375%… | $451.04 | 48.79B | — | — | -99% | -96% | — | — | — | — | 1356.00% |
| A | Agilent Technologies, Inc… | $146.77 | 41.61B | -35% | -57% | -89% | -54% | 96.67 | 6.22 | 6.04 | 23.72 | 673.00% |
| ALC | Alcon Inc. | $74.34 | 36.75B | -20% | -54% | -59% | -66% | 42.77 | 1.90 | 4.03 | 19.38 | 494.00% |
| ARGX | argenx SE | $832.35 | 50.91B | — | — | -73% | +138% | — | — | — | — | — |
| CAH | Cardinal Health, Inc. | $196.79 | 46.76B | -43% | -70% | — | -79% | 22.84 | -12.89 | 0.16 | 13.30 | -187.00% |
| EW | Edwards Lifesciences Corp… | $82.84 | 48.64B | -2% | -47% | -71% | -57% | 47.67 | 4.93 | 8.40 | 33.68 | 1155.00% |
| HLN | Haleon plc | $9.31 | 42.18B | +325% | -45% | — | -77% | 22.30 | 2.22 | 3.37 | 15.73 | -396.00% |
| IDXX | IDEXX Laboratories, Inc. | $720.21 | 57.51B | -40% | -46% | -89% | -67% | 48.13 | 31.77 | 11.85 | 35.33 | 1042.00% |
| RMD | ResMed Inc. | $245.22 | 35.94B | -6% | -37% | -85% | -32% | 28.88 | 6.78 | 7.86 | 20.96 | 984.00% |
| TAK | Takeda Pharmaceutical Com… | $13.59 | 42.85B | — | — | — | -64% | — | — | — | — | — |
| VEEV | Veeva Systems Inc. | $295.26 | 48.4B | — | — | -77% | -55% | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $451.04) − 1 = — (DCF, example).